BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16361230)

  • 1. Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host.
    Watabe T; Kishino H; Okuhara Y; Kitazoe Y
    Genetics; 2006 Mar; 172(3):1385-96. PubMed ID: 16361230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.
    Sato H; Kato K; Takebe Y
    Virology; 1999 May; 257(2):491-501. PubMed ID: 10329559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.
    Andrianov AM; Veresov VG
    J Biomol Struct Dyn; 2007 Jun; 24(6):597-608. PubMed ID: 17508782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop.
    Leal E; Silva WP; Sucupira MC; Janini LM; Diaz RS
    Virology; 2008 Nov; 381(2):222-9. PubMed ID: 18814897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of the V3 loop of a Thailand HIV isolate.
    Gupta G; Anantharamaiah GM; Scott DR; Eldridge JH; Myers G
    J Biomol Struct Dyn; 1993 Oct; 11(2):345-66. PubMed ID: 8286061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.
    Svicher V; Alteri C; Artese A; Zhang JM; Costa G; Mercurio F; D'Arrigo R; Alcaro S; Palù G; Clementi M; Zazzi M; Andreoni M; Antinori A; Lazzarin A; Ceccherini-Silberstein F; Perno CF;
    Antivir Ther; 2011; 16(7):1035-45. PubMed ID: 22024519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates.
    Andrianov AM
    J Biomol Struct Dyn; 2008 Oct; 26(2):247-54. PubMed ID: 18597546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage.
    Sander O; Sing T; Sommer I; Low AJ; Cheung PK; Harrigan PR; Lengauer T; Domingues FS
    PLoS Comput Biol; 2007 Mar; 3(3):e58. PubMed ID: 17397254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
    Andrianov AM; Anishchenko IV
    J Biomol Struct Dyn; 2009 Oct; 27(2):179-93. PubMed ID: 19583444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational preferences of the HIV-1 principal neutralizing determinant.
    Andrianov AM
    J Biomol Struct Dyn; 2005 Dec; 23(3):267-82. PubMed ID: 16218754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.
    Ebenbichler C; Westervelt P; Carrillo A; Henkel T; Johnson D; Ratner L
    AIDS; 1993 May; 7(5):639-46. PubMed ID: 7686374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local structural properties of the V3 loop of Thailand HIV-1 isolate.
    Andrianov AM
    J Biomol Struct Dyn; 2002 Jun; 19(6):973-89. PubMed ID: 12023800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.
    Hu Q; Trent JO; Tomaras GD; Wang Z; Murray JL; Conolly SM; Navenot JM; Barry AP; Greenberg ML; Peiper SC
    J Mol Biol; 2000 Sep; 302(2):359-75. PubMed ID: 10970739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest.
    Xu S; Huang X; Xu H; Zhang C
    J Microbiol; 2007 Oct; 45(5):441-6. PubMed ID: 17978804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conformation of the HIV-1 gp120 V3 loop. Structure functional analysis of the HIV-Haiti viral strain].
    Andrianov AM
    Tsitologiia; 2006; 48(11):948-57. PubMed ID: 17233480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.